Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Renewal process in JBM Hertzog Residence
2014-03-19

In February 2014, the JBM Hertzog residence community initiated a process of renewal. The review and reassessment of university symbols and traditions is nothing new; it takes place on a regular basis through the institution.

This means that various conversations take place to consult students on the evaluation of their residence’s values, symbols, systems and traditions in a changing South Africa. The university is deeply committed to continuously renewing its residence cultures through focused conversations in order to be more inspiring and welcoming to all students. The involvement of students in co-creating such spaces remains paramount.

The university regrets the deliberate and misleading information in the media on the process underway in JBM. The importance of student involvement consequently calls for the distribution of accurate information in order to avoid uncertainties, misunderstandings and incorrect perceptions.

It is therefore important to state the following regarding the current renewal process in JBM Hertzog:

1. No memorabilia or photos have been removed, and no final decisions have been taken in this regard. These decisions form an integral part of the consultation process described above.

2. The name of the residence (among other symbols) is part of the consultation process. It is also important to note that all suggested name changes at the UFS are subject to the approval of the institutional Naming Committee and the University Council.

3. The perception that this process is being used to eliminate certain unique cultural identities is incorrect. However, what this process aims to achieve is a more inclusive and welcoming residence culture, and throughout this will be done in consultation with all students.

All current residents of JBM Hertzog are invited to form part of this renewal process. In conclusion, the UFS wishes to convey its appreciation to the Residence Committee members and the residents for their positive attitude and continuous support during this very important process.

Prof Jonathan Jansen
Vice-Chancellor and Rector
University of the Free State
 

Issued by: Lacea Loader (Director: Communication and Brand Management)
Telephone: +27(0)51 401 2584 or +27 (0) 83 645 2454
E-mail: news@ufs.ac.za
Fax: +27 (0) 51 444 6393

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept